Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Water-dispersible magnetic carbon nanotubes as T2-weighted MRI contrast agents.

Liu Y, Hughes TC, Muir BW, Waddington LJ, Gengenbach TR, Easton CD, Hinton TM, Moffat BA, Hao X, Qiu J.

Biomaterials. 2014 Jan;35(1):378-86. doi: 10.1016/j.biomaterials.2013.09.079.

PMID:
24120046
2.

Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.

Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL, Wang LF.

Biomaterials. 2009 Oct;30(28):5114-24. doi: 10.1016/j.biomaterials.2009.06.004.

PMID:
19560199
3.

On the synthesis and magnetic properties of multiwall carbon nanotube-superparamagnetic iron oxide nanoparticle nanocomposites.

Narayanan TN, Mary AP, Shaijumon MM, Ci L, Ajayan PM, Anantharaman MR.

Nanotechnology. 2009 Feb 4;20(5):055607. doi: 10.1088/0957-4484/20/5/055607.

PMID:
19417354
4.

The behavior after intravenous injection in mice of multiwalled carbon nanotube / Fe3O4 hybrid MRI contrast agents.

Wu H, Liu G, Zhuang Y, Wu D, Zhang H, Yang H, Hu H, Yang S.

Biomaterials. 2011 Jul;32(21):4867-76. doi: 10.1016/j.biomaterials.2011.03.024.

PMID:
21459436
5.

Manganese ferrite nanoparticle micellar nanocomposites as MRI contrast agent for liver imaging.

Lu J, Ma S, Sun J, Xia C, Liu C, Wang Z, Zhao X, Gao F, Gong Q, Song B, Shuai X, Ai H, Gu Z.

Biomaterials. 2009 May;30(15):2919-28. doi: 10.1016/j.biomaterials.2009.02.001.

PMID:
19230966
6.

In vitro evaluation of the L-peptide modified magnetic lipid nanoparticles as targeted magnetic resonance imaging contrast agent for the nasopharyngeal cancer.

Chen YC, Min CN, Wu HC, Lin CT, Hsieh WY.

J Biomater Appl. 2013 Nov;28(4):580-94. doi: 10.1177/0885328212466685.

PMID:
23174955
7.

Colloidally stabilized magnetic carbon nanotubes providing MRI contrast in mouse liver tumors.

Liu Y, Muir BW, Waddington LJ, Hinton TM, Moffat BA, Hao X, Qiu J, Hughes TC.

Biomacromolecules. 2015 Mar 9;16(3):790-7. doi: 10.1021/bm501706x.

PMID:
25649901
8.

Magnetic nanobeads as potential contrast agents for magnetic resonance imaging.

Pablico-Lansigan MH, Hickling WJ, Japp EA, Rodriguez OC, Ghosh A, Albanese C, Nishida M, Van Keuren E, Fricke S, Dollahon N, Stoll SL.

ACS Nano. 2013 Oct 22;7(10):9040-8. doi: 10.1021/nn403647t.

PMID:
24047405
9.

Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.

Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S.

Biomaterials. 2011 Jul;32(20):4584-93. doi: 10.1016/j.biomaterials.2011.03.018.

PMID:
21458063
10.

Amalgamation of complex iron(III) ions and iron nanoclusters with MWCNTs as a route to potential T2 MRI contrast agents.

Kuźnik N, Tomczyk MM, Wyskocka M, Przypis Ł, Herman AP, Jędrysiak R, Koziol KK, Boncel S.

Int J Nanomedicine. 2015 May 14;10:3581-91. doi: 10.2147/IJN.S81381.

11.
12.

Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.

Cowger TA, Tang W, Zhen Z, Hu K, Rink DE, Todd TJ, Wang GD, Zhang W, Chen H, Xie J.

Theranostics. 2015 Aug 9;5(11):1225-32. doi: 10.7150/thno.12570.

13.

Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents.

Shieh DB, Cheng FY, Su CH, Yeh CS, Wu MT, Wu YN, Tsai CY, Wu CL, Chen DH, Chou CH.

Biomaterials. 2005 Dec;26(34):7183-91.

PMID:
15964622
14.

In vivo detection of magnetic labeled oxidized multi-walled carbon nanotubes by magnetic resonance imaging.

Li R, Wu R, Zhao L, Qin H, Wu J, Zhang J, Bao R, Zou H.

Nanotechnology. 2014 Dec 12;25(49):495102. doi: 10.1088/0957-4484/25/49/495102.

PMID:
25409786
15.

Noncovalent functionalization of carbon nanotubes with amphiphilic gd3+ chelates: toward powerful t1 and t2 MRI contrast agents.

Richard C, Doan BT, Beloeil JC, Bessodes M, Tóth E, Scherman D.

Nano Lett. 2008 Jan;8(1):232-6.

PMID:
18088153
16.

The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.

Lee PW, Hsu SH, Wang JJ, Tsai JS, Lin KJ, Wey SP, Chen FR, Lai CH, Yen TC, Sung HW.

Biomaterials. 2010 Feb;31(6):1316-24. doi: 10.1016/j.biomaterials.2009.11.010.

PMID:
19959224
17.

Ultrasmall water-soluble metal-iron oxide nanoparticles as T1-weighted contrast agents for magnetic resonance imaging.

Zeng L, Ren W, Zheng J, Cui P, Wu A.

Phys Chem Chem Phys. 2012 Feb 28;14(8):2631-6. doi: 10.1039/c2cp23196d.

PMID:
22273844
18.

Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.

Kumar M, Singh G, Arora V, Mewar S, Sharma U, Jagannathan NR, Sapra S, Dinda AK, Kharbanda S, Singh H.

Int J Nanomedicine. 2012;7:3503-16. doi: 10.2147/IJN.S32694.

19.

Hydrothermal synthesis of a highly sensitive T2-weigthed MRI contrast agent: zinc-doped superparamagnetic iron oxide nanocrystals.

Chen F, Bu W, Lu C, Chen G, Chen M, Shen X, Liu R, Shi J.

J Nanosci Nanotechnol. 2011 Dec;11(12):10438-43.

PMID:
22408922
20.

Gold-coated iron oxide nanoparticles as a T2 contrast agent in magnetic resonance imaging.

Ahmad T, Bae H, Rhee I, Chang Y, Jin SU, Hong S.

J Nanosci Nanotechnol. 2012 Jul;12(7):5132-7.

PMID:
22966533
Items per page

Supplemental Content

Support Center